ledipasvir/sofosbuvir (authorized generic) — Medica
Recurrent Hepatitis C Virus (HCV) Post-Liver Transplantation, Genotypes 5 or 6
Initial criteria
- age ≥ 18 years
- recurrent HCV after liver transplantation
- prescribed in combination with ribavirin
- prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or liver transplant physician affiliated with a transplant center
Approval duration
12 weeks